Corcept Therapeutics, Inc. (CORT)
113.35
-0.53
(-0.47%)
USD |
NASDAQ |
Aug 31, 16:00
113.34
0.00 (0.00%)
After-Hours: 20:00
Corcept Therapeutics Total Long Term Debt (Quarterly) : 7.504M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.504M |
| March 31, 2026 | 8.01M |
| December 31, 2025 | 5.023M |
| September 30, 2025 | 5.308M |
| June 30, 2025 | 5.588M |
| March 31, 2025 | 5.851M |
| December 31, 2024 | 6.107M |
| September 30, 2024 | 6.359M |
| June 30, 2024 | 5.625M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.552M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.501M |
| September 30, 2020 | 0.997M |
| June 30, 2020 | 1.486M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.541M |
| December 31, 2019 | 1.903M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 4.573M |
| March 31, 2017 | 10.11M |
| December 31, 2016 | 14.66M |
| September 30, 2016 | 18.72M |
| June 30, 2016 | 22.30M |
| March 31, 2016 | 25.04M |
| December 31, 2015 | 27.53M |
| September 30, 2015 | 29.64M |
| June 30, 2015 | 31.43M |
| March 31, 2015 | 32.78M |
| December 31, 2014 | 33.89M |
| September 30, 2014 | 34.65M |
| June 30, 2014 | 35.03M |
| March 31, 2014 | 35.11M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Liquidia Corp. | 182.90M |
| Eli Lilly & Co. | 49.62B |
| Abeona Therapeutics, Inc. | 18.59M |
| Indivior Pharmaceuticals, Inc. | 500.00M |
| Crinetics Pharmaceuticals, Inc. | 40.61M |